JP2024511425A - 免疫細胞dnaを定量するための方法および組成物 - Google Patents

免疫細胞dnaを定量するための方法および組成物 Download PDF

Info

Publication number
JP2024511425A
JP2024511425A JP2023558179A JP2023558179A JP2024511425A JP 2024511425 A JP2024511425 A JP 2024511425A JP 2023558179 A JP2023558179 A JP 2023558179A JP 2023558179 A JP2023558179 A JP 2023558179A JP 2024511425 A JP2024511425 A JP 2024511425A
Authority
JP
Japan
Prior art keywords
dna
cancer
immune cell
methylation
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023558179A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022204730A5 (https=
JP2024511425A5 (https=
Inventor
ユペン ヘ,
アリエル ジャイモビッチ,
アンドリュー ケネディ,
メロミット シンガー,
エミリー キャサリン ツァン,
ウィリアム ジェイ. グリーンリーフ,
Original Assignee
ガーダント ヘルス, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ガーダント ヘルス, インコーポレイテッド filed Critical ガーダント ヘルス, インコーポレイテッド
Publication of JP2024511425A publication Critical patent/JP2024511425A/ja
Publication of JPWO2022204730A5 publication Critical patent/JPWO2022204730A5/ja
Publication of JP2024511425A5 publication Critical patent/JP2024511425A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2023558179A 2021-03-25 2022-03-25 免疫細胞dnaを定量するための方法および組成物 Pending JP2024511425A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166200P 2021-03-25 2021-03-25
US63/166,200 2021-03-25
PCT/US2022/071365 WO2022204730A1 (en) 2021-03-25 2022-03-25 Methods and compositions for quantifying immune cell dna

Publications (3)

Publication Number Publication Date
JP2024511425A true JP2024511425A (ja) 2024-03-13
JPWO2022204730A5 JPWO2022204730A5 (https=) 2025-04-01
JP2024511425A5 JP2024511425A5 (https=) 2025-04-01

Family

ID=81346077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023558179A Pending JP2024511425A (ja) 2021-03-25 2022-03-25 免疫細胞dnaを定量するための方法および組成物

Country Status (4)

Country Link
US (1) US20240344115A1 (https=)
EP (1) EP4314329A1 (https=)
JP (1) JP2024511425A (https=)
WO (1) WO2022204730A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025038399A1 (en) * 2023-08-11 2025-02-20 Guardant Health, Inc. Methylated enrichment methods for single-molecule genetic and epigenetic sequencing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019521673A (ja) * 2016-06-07 2019-08-08 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 疾患および状態の分析のためのセルフリーdnaメチル化パターン
JP2020504606A (ja) * 2016-12-22 2020-02-13 ガーダント ヘルス, インコーポレイテッド 核酸分子を解析するための方法およびシステム
US20200248272A1 (en) * 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US20030017081A1 (en) 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
AU2002359522A1 (en) 2001-11-28 2003-06-10 Applera Corporation Compositions and methods of selective nucleic acid isolation
CA2519860C (en) 2003-03-21 2018-01-16 Santaris Pharma A/S Short interfering rna (sirna) analogues
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9116118B2 (en) 2012-06-08 2015-08-25 Pacific Biosciences Of California, Inc. Modified base detection with nanopore sequencing
GB2533006B (en) 2012-09-04 2017-06-07 Guardant Health Inc Systems and methods to detect copy number variation
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
US11384382B2 (en) * 2016-04-14 2022-07-12 Guardant Health, Inc. Methods of attaching adapters to sample nucleic acids
KR102610098B1 (ko) 2016-07-06 2023-12-04 가던트 헬쓰, 인크. 무세포 핵산의 프래그멘톰 프로파일링을 위한 방법
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
US20220154285A1 (en) * 2020-09-30 2022-05-19 Guardant Health, Inc. Analysis of methylated dna comprising methylation-sensitive or methylation-dependent restrictions
WO2024073508A2 (en) * 2022-09-27 2024-04-04 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019521673A (ja) * 2016-06-07 2019-08-08 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 疾患および状態の分析のためのセルフリーdnaメチル化パターン
JP2020504606A (ja) * 2016-12-22 2020-02-13 ガーダント ヘルス, インコーポレイテッド 核酸分子を解析するための方法およびシステム
US20200248272A1 (en) * 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HOUSEMAN, EUGENE ANDRES, ET AL.: "DNA methylation arrays as surrogate measures of cell mixture distribution", BMC BIOINFORMATICS, vol. 13:86, JPN6026007897, 8 May 2012 (2012-05-08), pages 1 - 16, ISSN: 0005805447 *
KOESTLER, DEVIN C., ET AL.: "Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL)", BMC BIOINFORMATICS, vol. 17:120, JPN6026007898, 8 March 2016 (2016-03-08), pages 1 - 21, ISSN: 0005805448 *
MOSS, JOSHUA, ET AL.: "Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in heal", NATURE COMMUNICATIONS, vol. 9:5068, JPN6026007899, 29 November 2018 (2018-11-29), pages 1 - 12, ISSN: 0005805446 *

Also Published As

Publication number Publication date
US20240344115A1 (en) 2024-10-17
EP4314329A1 (en) 2024-02-07
WO2022204730A1 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
JP7717057B2 (ja) メチル化分配アッセイにおいて無細胞dnaを解析するための組成物および方法
JP2023544721A (ja) 分配およびメチル化依存性ヌクレアーゼを使用してdnaを解析するための組成物および方法
US20240150844A1 (en) Compositions and methods for enriching methylated polynucleotides
US20240167099A1 (en) Detection of epigenetic status using sequence-specific degradation
US20240191290A1 (en) Methods for detection and reduction of sample preparation-induced methylation artifacts
US20240229113A1 (en) Methods and compositions for detecting nucleic acid variants
US20250236916A1 (en) Enrichment of aberrantly modified dna
JP2023547620A (ja) 分配および塩基変換を使用してdnaを解析するための組成物および方法
US20250101494A1 (en) Methods for analyzing cytosine methylation and hydroxymethylation
EP4453241A1 (en) Methods and systems for combinatorial chromatin-ip sequencing
US20250084464A1 (en) Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
US20240263241A1 (en) Methods and compositions for copy-number informed tissue-of-origin analysis
US20240093292A1 (en) Quality control method
WO2024073508A2 (en) Methods and compositions for quantifying immune cell dna
JP2024511425A (ja) 免疫細胞dnaを定量するための方法および組成物
JP2025542261A (ja) 統合された対象および全ゲノム体細胞およびdnaメチル化シーケンシングワークフロー
US20240345104A1 (en) Compositions and methods for assaying circulating molecules
WO2025155895A1 (en) Nucleic acid modification profiling method
WO2024229433A1 (en) Methods for analysis of dna methylation
WO2025235889A1 (en) Methods involving multiplexed pooled pcr

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250324

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260227

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260227